Senate committee advances Dr. Oz to lead CMS
Democrats on the Senate Finance Committee criticized the physician and TV personality ahead of the vote Tuesday for avoiding questions about potential cuts to Medicaid.
Uncategorized
Wave’s Duchenne Exon-Skipper Reverses Muscle Damage in Mid-Stage Trial
WVE-N531, an oligonucleotide, elicited significant functional benefit and reversal of muscle damage in the Phase II FORWARD-53 trial. Wave plans to file for accelerated approval of the candidate in 2026.
Wave’s Duchenne Exon-Skipper Reverses Muscle Damage in Mid-Stage Trial Read More »
Bayer Jumps on Chinese Partnership Train with Oncology Deal
The German conglomerate announced a licensing agreement with Puhe BioPharma for a PRMT5 inhibitor used in a variety of cancers. Financial details of the deal were not disclosed.
Bayer Jumps on Chinese Partnership Train with Oncology Deal Read More »
Judge dismisses lawsuit against Wells Fargo over prescription drug costs
The decision could throw cold water on potential copycat suits seeking to hold large, self-funded employers responsible if they overpay for prescription drugs.
Judge dismisses lawsuit against Wells Fargo over prescription drug costs Read More »
Dolores musculares y estrés: La relación entre emociones y dolor físico
En la vida cotidiana, muchas personas experimentan dolores musculares sin una causa física evidente. Factores como el estrés, la ansiedad y las emociones reprimidas pueden desempeñar un papel clave en la aparición de molestias físicas. La conexión entre la m …
Dolores musculares y estrés: La relación entre emociones y dolor físico Read More »
Eisai Lowers Sales Expectations for Leqembi Again, Citing Slow US Uptake
Eisai’s new fiscal 2027 forecast for Leqembi is roughly 50% lower than its projections a year ago.
Eisai Lowers Sales Expectations for Leqembi Again, Citing Slow US Uptake Read More »
GSK Wins FDA Nod for First Oral UTI Antibiotic in Almost 30 Years
Blujepa, which treats UTIs in female patients aged 12 and up with common and uncomplicated infections, will hit the market in the second half of this year.
GSK Wins FDA Nod for First Oral UTI Antibiotic in Almost 30 Years Read More »
Tariffs Would Impede Access to Affordable Drugs, Industry Warns
Trump’s proposed tariffs on the EU would increase manufacturing costs for pharma companies and would stall medical innovation, according to the results of a recent survey by the Biotechnology Innovation Organization.
Tariffs Would Impede Access to Affordable Drugs, Industry Warns Read More »
Trump’s Pharma Tariffs, Monarez for CDC, Novo’s New Obesity Play, More
President Donald Trump continues to warn of tariffs on the pharmaceutical industry; Susan Monarez replaces Dave Weldon as CDC director nominee; Novo Nordisk joins the triple-G race; Alnylam wins approval for Amvuttra in ATTR-CM; and Cassava Sciences ends development of simufilam in Alzheimer’s.
Trump’s Pharma Tariffs, Monarez for CDC, Novo’s New Obesity Play, More Read More »
BioSpace Presents the World Atlas of GLP-1s
Eli Lilly and Novo Nordisk are in a global battle for dominance in the weight loss space. BioSpace takes a look at the territory covered and what’s to come.